We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Peritoneal Dialysis Patients More Satisfied with Their Care

By HospiMedica staff writers
Posted on 25 Feb 2004
A study has found that kidney disease patients who used peritoneal dialysis at home were 1.5 times more likely to rate their care as excellent than patients who used hemodialysis equipment at a dialysis center. More...
The findings were published in the February 11, 2004, issue of the Journal of the American Medical Association (JAMA).

Hemodialysis patients must spend three to four hours, three times a week, attached to a blood-cleaning machine at a dialysis center. Peritoneal dialysis patients, in contrast, can perform the 30-minute procedure four times a day outside the center on portable equipment, after training, and need to return to the center only monthly for checkups. Peritoneal dialysis involves surgically and permanently placing a soft plastic tube or catheter into the lining of the belly. A sterile cleansing fluid is flushed through the catheter and allowed to dwell in the belly until wastes pass across the lining into the fluid. Once filled with wastes, the fluid is then removed from the belly via the same catheter.

In the study, researchers surveyed 656 patients at dialysis centers. The results showed that 85% of peritoneal dialysis patients rated their care as "excellent,” compared to only 56% of hemodialysis patients. Currently, only 10% of the more than 100,000 patients starting dialysis each year use peritoneal dialysis. The researchers speculate that the pressure to fill large, hemodialysis centers nationwide may be part of the reason for this, as well as lack of information provided on peritoneal dialysis.

"Our study suggests that the vast majority of patients undergoing hemodialysis could be making a decision on dialysis treatment on the basis of very inadequate information,” said Haya Rubin, M.D., Ph.D., professor of medicine at Johns Hopkins Medical Institutions (Baltimore, MD, USA) and a member of the research team.




Related Links:
Johns Hopkins

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Medical Monitor
VITALMAX 4100SL
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.